Windtree Therapeutics Enters Material Definitive Agreement
Ticker: WINTW · Form: 8-K · Filed: Jul 3, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | Jul 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, equity-securities, corporate-action
TL;DR
Windtree Therapeutics just signed a big deal involving unregistered equity sales.
AI Summary
On June 27, 2025, Windtree Therapeutics, Inc. entered into a material definitive agreement related to unregistered sales of equity securities. The company, formerly known as Discovery Laboratories Inc. and Ansan Pharmaceuticals Inc., is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing indicates a significant corporate action, potentially involving new financing or strategic partnerships, which could impact the company's future operations and stock value.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities, which can sometimes indicate financial distress or dilution for existing shareholders.
Key Numbers
- 001-39290 — SEC File Number (Windtree Therapeutics' SEC filing identifier)
- 94-3171943 — IRS Employer Identification No. (Windtree Therapeutics' tax identification number)
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- Discovery Laboratories Inc. /DE/ (company) — Former Company Name
- Ansan Pharmaceuticals Inc (company) — Former Company Name
- June 27, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Windtree Therapeutics?
The filing indicates the agreement is related to unregistered sales of equity securities.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 27, 2025.
What were Windtree Therapeutics' former company names?
Windtree Therapeutics was formerly known as Discovery Laboratories Inc. /DE/ and Ansan Pharmaceuticals Inc.
In which state is Windtree Therapeutics incorporated?
Windtree Therapeutics is incorporated in Delaware.
What is Windtree Therapeutics' SIC code and industry?
Windtree Therapeutics has a SIC code of 2836 and operates in the Biological Products (no diagnostic substances) industry.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 3, 2025 regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).